For decades, the standard clinical framing was that insomnia in depression was a symptom of depression. Treat the depression, and the insomnia would resolve. In practice, this was often wrong. Roughly half of people with depression continue to have significant insomnia after their depression has responded to treatment, and residual insomnia is one of the strongest predictors of relapse.

The picture has now shifted. Insomnia and depression are understood as bidirectionally related: each raises the risk of the other, and each can independently drive the other. That reframing changes what effective treatment looks like.

The evidence for the bidirectional link

Several strands of evidence converge:

Insomnia as a risk factor for future depression. People with insomnia but no current depression are at meaningfully higher risk of developing depression over the following one to five years. This has been shown in multiple large cohort studies. Insomnia is not just a warning sign; it is a modifiable risk factor.

Residual insomnia predicts depression relapse. In people who have been treated for depression, sleep disturbance that persists after mood remission substantially increases the risk of the depression coming back.

Shared neurobiology. Insomnia and depression share overlapping mechanisms: HPA-axis dysregulation, elevated inflammation (IL-6, CRP), reduced BDNF, altered emotional regulation and rumination, and disrupted default mode network connectivity. Treating one often affects the other because you are targeting shared substrate.

Direct treatment evidence. A 2024 meta-analysis (Blom et al., Psychotherapy and Psychosomatics) of RCTs of CBT-I in adults with comorbid major depressive disorder found significant improvements in depression response and remission at post-treatment. Multiple earlier systematic reviews and meta-analyses have shown similar results: treating insomnia with CBT-I improves depression outcomes, in some studies with effect sizes comparable to antidepressant treatment.

Why this matters clinically

The old framing pushed the treatment sequence one way: treat the depression first, then see what remains. The current evidence supports a different approach:

  • When insomnia is prominent, treat it directly. Do not wait for antidepressant treatment to fix it (often it will not).
  • Where possible, treat insomnia in parallel with depression treatment, not sequentially.
  • Residual insomnia after mood improvement should be actively treated to reduce relapse risk.
  • For some clients, CBT-I is a reasonable first-line intervention for a mixed insomnia-depression presentation, particularly when depression severity is mild to moderate.

None of this replaces standard depression treatment (CBT for depression, behavioural activation, antidepressant medication where appropriate). It sits alongside it as a distinct and effective lever.

Mechanisms: how sleep treatment improves mood

Several plausible pathways, likely operating together:

Reduced rumination. Chronic insomnia amplifies negative rumination, both at night (when there is nothing to do but think) and during the day (from cognitive fatigue). CBT-I reduces rumination directly, and reduced rumination is one of the mediating variables between insomnia improvement and depression improvement.

Restored emotional regulation. REM sleep, and sleep generally, is central to overnight emotional processing. Chronic sleep disruption blunts this, leaving negative affect more sticky. Restoring sleep restores this processing.

Reduced inflammation. Chronic insomnia is associated with elevated inflammatory markers, and inflammation is bidirectionally linked to depression. Treating insomnia reduces inflammatory markers, at least in some populations.

Improved cognitive control. Sleep-restored prefrontal function supports the cognitive-control side of therapy work (behavioural activation, cognitive restructuring, values-based action).

Reduced hopelessness. For many people with chronic insomnia, part of the hopelessness of depression comes from the sheer exhaustion of the nights. Restoring sleep changes the felt sense of the day.

What treatment actually looks like

If you have significant insomnia alongside depression, options include:

CBT-I as a first-line insomnia intervention. Standard CBT-I protocols (4 to 8 sessions) work in the context of comorbid depression. Some clinicians use adapted protocols (CBT-I integrated with cognitive therapy for depression) when both conditions are moderate to severe.

Coordination with any medication. Some antidepressants are more sleep-friendly than others (mirtazapine, trazodone, some SSRIs) and prescribing decisions can take insomnia into account. If you are on a benzodiazepine or Z-drug for sleep, CBT-I can support a coordinated taper (see our companion piece on tapering with CBT-I support).

Behavioural activation alongside sleep work. The two treatments complement each other well. Behavioural activation addresses the withdrawal and inactivity of depression; CBT-I addresses the arousal and sleep pattern.

Treatment of any other maintaining factors. Chronic pain, anxiety, ADHD, trauma. All of these interact with the insomnia-depression loop and often need direct attention.

The trap of "just get more sleep"

One clinical caveat: telling someone with insomnia and depression to "just get more sleep" or "just improve your sleep hygiene" is neither helpful nor accurate. Sleep hygiene alone does very little for chronic insomnia, and the effort to force sleep often makes both insomnia and low mood worse.

Effective insomnia treatment is structured, protocol-based, and matched to what is actually driving the sleep problem. That is a different thing from generic sleep advice.

Where to start

If you are navigating both insomnia and depression, and no one has offered you a proper conversation about treating the insomnia directly, that is worth pursuing. It is often the single most impactful thing that can shift the picture, particularly when depression has been slow to respond to standard approaches.

References

  • Blom K et al. Psychological treatment of comorbid insomnia and depression: A double-blind randomized placebo-controlled trial. Psychother Psychosom, 2024.
  • CBT-I to treat major depressive disorder with comorbid insomnia. J Affect Disord, 2024.
  • Vargas I et al. From better sleep to improved mood: a review of the biopsychosocial pathways for CBT-I's antidepressant effects. Curr Sleep Med Rep, 2026.
  • Effect of insomnia treatments on depression: A systematic review and meta-analysis.
  • Advances in the research of comorbid insomnia and depression: mechanisms, impacts, and interventions. Front Psychiatry, 2025.